KemPharm, Inc.
(NASDAQ : KMPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MNKMallinckrodt Plc
1.58%34.6821.1%$126.04m
PRGOPerrigo Co. Plc
3.64%72.966.7%$115.08m
SHPGShire PLC Sponsored ADR
-0.63%170.420.4%$114.29m
ENDPEndo International Plc
-1.94%15.648.9%$89.03m
JAZZJazz Pharmaceuticals Plc
0.40%173.812.2%$72.23m
ICPTIntercept Pharmaceuticals, Inc.
0.20%103.4218.7%$68.63m
SAGESAGE Therapeutics, Inc.
2.03%152.089.6%$57.16m
UTHRUnited Therapeutics Corporation
-2.97%125.6114.4%$50.56m
CTLTCatalent Inc
0.39%40.942.6%$47.83m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.59%136.066.8%$43.22m
PTLAPortola Pharmaceuticals, Inc.
0.04%25.597.7%$40.54m
SUPNSupernus Pharmaceuticals, Inc.
2.99%44.806.2%$40.22m
ICLRICON Plc
0.23%143.684.2%$39.99m
ZGNXZogenix, Inc.
1.15%48.6011.9%$37.44m
HZNPHorizon Pharma plc
-0.15%20.577.5%$32.74m

Company Profile

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.